Overview

Study of 2% Chlorhexidine Gluconate-Impregnated Bath Cloths to Prevent MRSA Colonization in Complex Continuing Care

Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine whether daily bathing with 2% chlorhexidine gluconate-impregnated antiseptic cleanser (CHG) significantly reduces incidence of colonization of hospitalized patients with methicillin-resistant Staphylococcus aureus (MRSA). Investigators postulate that daily bathing with CHG significantly reduces incidence of colonization of hospitalized patients with MRSA.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Baycrest
Treatments:
Anti-Infective Agents, Local
Chlorhexidine
Chlorhexidine gluconate
Criteria
Inclusion Criteria:

- MRSA-negative (at enrollment) inpatient of Complex Continuing Care program

Exclusion Criteria:

- MRSA-positive (at enrollment) inpatient of Complex Continuing Care program